Screening colonoscopy in Australia

被引：5

作者：

Singh, Rajvinder ^{[1
,2
]}

Mangira, Dileep ^{[3
]}

Kawano, Hiroshi ^{[4
]}

Matsuda, Takashia ^{[5
]}

机构：

[1] Lyell McEwin Hosp, Adelaide, SA, Australia

[2] Univ Adelaide, Adelaide, SA, Australia

[3] Flinders Med Ctr, Adelaide, SA, Australia

[4] St Marys Hosp, Tokyo, Japan

[5] Natl Canc Ctr, Tokyo, Japan

来源：

DIGESTIVE ENDOSCOPY | 2015年 / 27卷

关键词：

colorectal cancer; fecal occult blood test; image-enhanced endoscopy; National Bowel Cancer Screening Program; pilot program; COLORECTAL-CANCER; ADENOMA DETECTION; METAANALYSIS;

D O I：

10.1111/den.12419

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Colorectal cancer (CRC) is a global epidemic predominantly affecting Western countries. It is the second leading cause of cancer-related deaths in Australia with one in 12 Australians affected by this condition by the age of 85 years. Appropriate preventive measures by screening followed by colonoscopy can detect cancer and precancerous lesions, which are potentially curable. The National Bowel Cancer Screening Program (NBCSP) is a national screening program implemented by the Australian Government aimed at reducing morbidity and mortality from bowel cancer by actively recruiting and screening the target population. The long-term goal of the program is to include the at-risk population (50-74 years of age) in a biennial screening program. Newer technologies could have a potential role in screening programs by enhancing adenoma detection rates. However, until more evidence is available, improving screening uptake and bowel preparation strategies are the prime focus in reducing CRC-related morbidity and mortality.

引用

页码：30 / 34

页数：5

共 29 条

[21] The Efficacy of Cap-Assisted Colonoscopy in Polyp Detection and Cecal Intubation: A Meta-Analysis of Randomized Controlled Trials [J].